Category: General Biotechnology

Natural Products: A New Golden Age in Drug Development?

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. We live in a time of miracles and wonders, where a return to nature holds the promise of a new golden age of drug development for the benefit […]


Drug Patent Expirations for Oct 15, 2015

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. ALOXI (palonosetron hydrochloride) Helsinn Hlthcare Patent number: 5,202,333 Expiration Date: Oct 13, 2015 VARITHENA (polidocanol) Provensis Patent number: RE 40,640 Expiration Date: Oct 14, 2015 For more information […]


Why data exclusivity is the new patent protection

Journal of Commercial Biotechnology
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology

Why data exclusivity is the new patent protection

Go to paper

ABSTRACT:   

The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.

Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:

  • Management
  • Policy
  • Finance
  • Law
  • Regulation
  • Bioethics

For more information, see the Journal of Commercial Biotechnology website


Drug Patent Expirations for Oct 8, 2015

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. PRILOSEC OTC (omeprazole magnesium) Astrazeneca Pharms Patent number: 5,817,338 Expiration Date: Oct 6, 2015 LETAIRIS (ambrisentan) Gilead Patent number: 7,601,730 Expiration Date: Oct 7, 2015 LETAIRIS (ambrisentan) Gilead […]


Drug Patent Expirations for Oct 1, 2015

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. VALCYTE (valganciclovir hydrochloride) Hoffmann La Roche Patent number: 6,083,953 Expiration Date: Sep 29, 2015 MYCAMINE (micafungin sodium) Astellas Patent number: 6,265,536 Expiration Date: Sep 29, 2015 DEXFERRUM (iron […]


The relevance and importance of business development and licensing in the biopharmaceutical industry.

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
The relevance and importance of business development and licensing in the biopharmaceutical industry.
Go to paperABSTRACT: The importance of the busines…


The reason there is no generic Daraprim

Much has been written on the controversial price increase of Daraprim. Daraprim treats malaria and another parasitic infection, toxoplasmosis. It was acquired by Turing Pharma from Impax Laboratories and shortly after the price was raised from $13.50 a tablet to $750 a tablet. The led to a quick outcry, followed by a) a defense by Turing of their drug […]


Drug Patent Expirations for Sep 24, 2015

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. SOMAVERT (pegvisomant) Pharmacia And Upjohn Patent number: 6,057,292 Expiration Date: Sep 21, 2015 DIPRIVAN (propofol) Fresenius Kabi Usa Patent number: 5,908,869 Expiration Date: Sep 22, 2015 DIPRIVAN (propofol) […]